原名「台灣學術線上」
包含TAO期刊庫 + TAO書籍庫 + 論文 + 史料文獻
首頁 | 關於TAO | 瀏覽 | 進階查詢 | 參考工具 | 會員服務 | 已購專書 | RSS服務 | 電子報 | FAQ  
查詢範圍:
   
查詢模式:
熱門查詢詞:
dvd步進電機diagram de銘傳
   
   
   
     
   
 
項次 書目
1
題名:TREATMENT RESULTS OF HYPOPHARYNGEAL CANCER BASED ON DEFINITIVE RADIOTHERAPY     (22點)
下咽癌之放射治療結果與預後因子分析
著者:Pang-Yu Chen(陳邦瑜) ;Shih-Neng Yang(楊世能) ;Ji-An Liang(梁基安) ;Ming-Hsui Tsai(蔡銘修) ;Shang-Wen Chen(陳尚文) ;Fang-Jen Lin(林芳仁)
出版地區:台灣
出版城市:台北市
學科:醫學綜合
關鍵字:下咽癌 ; 放射治療 ; 聲帶保留 ; 預後因子 ; Hypopharyngeal cancer ; Radiotherapy ; Laryngeal preservation ; Prognostic factor
刊名:Therapeutic Radiology and Oncology
頁碼:63-73
語言:英語
摘要: 中文摘要PDF ; 英文摘要PDF

目的:分析一至四期下咽癌病人接受聲帶保留放射治療之治療結果與預後因子。材料與方法:自 1996 年 1 月至 2005 年 6 月,共有 130 位一至四期之下咽癌病人完成聲帶保留放射治療,其中 126 位病患的腫瘤源發部位為梨狀竇。放射治療劑量為每日 1.8 Gy,總劑量從68.4 至 82.4 Gy(中位值 70.2 Gy),98 位病患接受 cisplatin 合併 5-fluorouracil 的化學治療。分析這些病人之臨床資料後,以 Kaplan-Meier 方式計算五年之整體存活率、疾病有關存活率、及局部腫瘤控制率,並以 Cox’s proportional hazards model 進行多變數分析尋找預後有關因子。 結果:治療後的追蹤時間中位數是 39 個月(範圍從14至120個月)。第一二期,三期,四期的病患的五年整體存活率及疾病有關存活率分別為 56%/64%,30%/43%,及 14%/15%。而所有病人,第一二期,三期,四期病患之五年腫瘤局部控制率分別為 34%,66%,46%,18%(p 值為0.004)。多變數分析結果顯示第四期的腫瘤為導致局部復發的預後因子(p 值為 0.002)。 結論:第一二期之下咽癌病人適合接受聲帶保留放射治療,至於第三期病人因半數發生局部復發,所以聲帶保留治療方式的角色仍有待進一步研究。此外第四期之病患以同樣治療方式之預後較差,應合併更積極的治療策略。
Purpose : To investigate the prognostic factors for survival and locoregional control in patients with stage I-IV hypopharyngeal cancer (HPC) treated with curative-intent laryngeal preservation radiotherapy (LPRT). Materials and Methods : From January 1996 through June 2005, 130 patients with stage I-IV squamous cell carcinoma of the hypopharynx were enrolled in this retrospective analysis. The pyriform sinus was the principle site of involvement in 126 cases. All patients received 1.8 Gy daily up to a total dose of 68.4 to 82.4 Gy (median 70.2 Gy). Ninety-eight patients (75.4%) received chemotherapy combined with cisplatin plus 5-fluorouracil (5-FU). Actuarial survival (AS), disease-specific survival (DSS) and local relapse-free survival (LRFS) were calculated, and multivariate analyses were performed using the Cox’s proportional hazards model. Results : With a median follow-up duration of 39 months (range 14 to 120 months), the 5-year AS/DSS was 56%/64% for patients with stage I-II disease, 30%/43% for stage III disease, and 14%/15% for those with stage IV disease. The 5-year LRFS rate was 34% for all patients, 66% for patients with stage I-II disease, 46% for stage III disease, and 18% for those with stage IV disease (p = 0.004). Multivariate analyses showed that stage IV disease was an independent prognostic factor for local recurrence (p = 0.002). Conclusions : Patients with stage I-II disease are suitable for LPRT. Indiscriminate use of LPRT for stage III disease is still problematic because nearly half of these patients had unsuccessful outcomes. For most patients with stage IV, the treatment results were poor. More aggressive combined modality treatment should be considered.


    

本卷期目次
Therapeutic Radiology and Oncology
強度調控放射治療之表面劑量測量/ 劉國基蕭安成趙敏梁基安楊世能蘇經雄施文彬陳信雄
Prognositc factor analysis for lung cancer patientswith superior vena cava syndrome treated withradiation therapy/ Ying-Chieh YangJian-Sheng JanJin-Ching Lin
Treatment Results of Hypopharyngeal Cancer based/ Pang-Yu ChenShih-Neng YangJi-An LiangMing-Hsui Tsai
晚期胸腺癌的治療與預後因子/ 莊富成張慶雄陳建勳胡渝昌
Three-dimentional conformal radiotherapy with or without oral Thalidomide for advanced hepatocellular carcinoma / Ming-Hsien LiYu-Chang LiuYu-Jen ChenYu-Wen LiKou-Hwa Chang
嗅神經母細胞瘤: 強度調控放射治療經驗/ 葉啟源賴鵬安林玉卿楊光明
評估使用照野中之照野技術于乳房保留手術乳癌病患之治療/ 涂振邦張智穎陳顯鑫陳為立簡哲民徐椿壽
強度調控放射治療之表面劑量測量/ 劉國基蕭安成趙敏梁基安楊世能蘇經雄施文彬陳信雄
DEFINITIVE RADIOTHERAPY FOR ANEURYSMAL BONE CYST OF THE LUMBAR VERTEBRA-A CASE REPORT WITH A SHORT-TERM FOLLOW-UP AND REVIEW OF THE LITERATURE/ Ming-Hsiang ChuWen-Lin HsuHsi-Sheng ChsiaDai-Wei LiuTzu-Hwei WangYi-Ju SuYu-Nong Wang
嗅神經母細胞瘤:強度調控放射治療經驗/ 葉啟源賴鵬安林玉卿楊光明
TREATMENT RESULTS OF HYPOPHARYNGEAL CANCER BASED ON DEFINITIVE RADIOTHERAPY/ Pang-Yu ChenShih-Neng YangJi-An LiangMing-Hsui TsaiShang-Wen ChenFang-Jen Lin
晚期胸腺癌的治療與預後因子/ 莊富成張慶雄陳建勳胡渝昌
THREE-DIMENTIONAL CONFORMAL RADIOTHERAPY WITH OR WITHOUT ORAL THALIDOMIDE FOR ADVANCED HEPATOCELLULAR CARCINOMA/ Ming-Hsien LiYu-chang LiuYu-Jen ChenYu-Wen LiKou-Hwa Chang
PROGNOSITC FACTOR ANALYSIS FOR LUNG CANCER PATIENTS WITH SUPERIOR VENA CAVA SYNDROME TREATED WITH RADIATION THERAPY/ Ying-Chieh YangJian-Sheng JanJin-Ching Lin
 
   
 
   

與TAO合作 | 隱私與版權聲明 | 聯絡方式 | 下載Adobe Reader
地址:台北市中正區(100)北平東路30-12號3樓
電話:(02)2393-6968 傳真:(02)2393-6877
Email: service@wordpedia.com
Wordpedia Family: 學校、企業版入口 | 遠流影音館
Copyright©2011 Wordpedia Co., Ltd. All Rights Reserved.